THE SYSTEMIC INFLAMMATORY RESPONSE IDENTIFIES PATIENTS WITH ADVERSE CLINICAL OUTCOME FROM IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA

Ambreen Muhammed  ¹     Matthias Pinter  ²     Bernhard Scheiner  ²     Lorenz Balcar  ²     Thomas Marron  ³     Tomi Jun  ³     Sirish Sirish Dharmapuri  ³     Celina Ang  ³     Anwaar Saeed  ⁴     Hannah Hildebrand  ⁴     Musharraf Navaid  ⁵     Anushi Bulumulle  ⁵     Mahvish Muzaffar  ⁵     Abdul Rafeh Naqash  ⁵     Anuhya Gampa  ⁶     Anjana Pillai  ⁶     Yinghong Wang  ⁷     Uqba Khan  ⁸     Pei-Chang Lee  ⁹     Yi-Hsiang Huang  ⁹     Dominik Bettinger  ¹⁰     Yehia I. Abugabal  ¹⁰     Ahmed Kaseb  ¹⁰     Tiziana Pressiani  ¹¹     Nicola Personeni  ¹²     Lorenza Rimassa  ¹²     Naoshi Nishida  ¹³     Masatoshi Kudo  ¹³     Arndt Vogel  ¹⁴     Alessio Cortellini  ¹⁴     Rohini Sharma  ¹⁴     David Pinato  ^14    
1 Imperial College London, London, United Kingdom
² Medical University Vienna, Wien, Austria
³ Mount Sinai Hospital, New York, United States
⁴ Kansas University Cancer Center, Kansas, United States
⁵ East Carolina University, Greenville, United States
⁶ University of Chicago Medicine, Chicago, United States
⁷ The University of Texas MD Anderson Cancer Center, Houston, United States
⁸ Weill Cornell Medicine/New York Presbyterian Hospital, New York, United States
⁹ Taipei Veterans General Hospital, Taipei, Taiwan
¹⁰ University of Freiburg, Freiburg, Germany
¹¹ Humanitas Clinical and Research Center - IRCCS, Milan, Italy
¹² Humanitas University, Milan, Italy
¹³ Kindai University Faculty of Medicine, Osaka, Japan
¹⁴ Medizin. Hochschule Hannover, Hannover, Germany

Session
Liver & biliary (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)